BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35406392)

  • 1. Proton Beam Therapy in Managing Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.
    Lee CH; Chen AH; Hung SP; Hsieh CE; Tseng JH; Chen PJ; Cheng JY; Chang JT; Chan KM; Lin SM; Lin CC; Chen WT; Chen WY; Huang BS
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton beam therapy for hepatocellular carcinoma with bile duct invasion.
    Iizumi T; Okumura T; Hasegawa N; Ishige K; Fukuda K; Seo E; Makishima H; Niitsu H; Takahashi M; Sekino Y; Takahashi H; Takizawa D; Oshiro Y; Baba K; Murakami M; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
    BMC Gastroenterol; 2023 Aug; 23(1):267. PubMed ID: 37537527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.
    Tanaka T; Kuzuya T; Ishigami M; Ito T; Ishizu Y; Honda T; Ishikawa T; Fujishiro M
    Oncology; 2020; 98(9):621-629. PubMed ID: 32434180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.
    Hung SP; Huang BS; Hsieh CE; Lee CH; Tsang NM; Chang JT; Chen JS; Chou WC; Tseng JH; Hong JH
    Am J Clin Oncol; 2020 Mar; 43(3):180-186. PubMed ID: 31764017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
    J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.
    Hong TS; DeLaney TF; Mamon HJ; Willett CG; Yeap BY; Niemierko A; Wolfgang JA; Lu HM; Adams J; Weyman EA; Arellano RS; Blaszkowsky LS; Allen JN; Tanabe KK; Ryan DP; Zhu AX
    Pract Radiat Oncol; 2014; 4(5):316-322. PubMed ID: 25194100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory-gated Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract without Fiducial Markers.
    Mizuhata M; Takamatsu S; Shibata S; Bou S; Sato Y; Kawamura M; Asahi S; Tameshige Y; Maeda Y; Sasaki M; Kumano T; Kobayashi S; Yamamoto K; Tamamura H; Gabata T
    Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29466294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma with bile duct tumor thrombus: surgical outcomes and the prognostic impact of concomitant major vascular invasion.
    Kasai Y; Hatano E; Seo S; Taura K; Yasuchika K; Uemoto S
    World J Surg; 2015 Jun; 39(6):1485-93. PubMed ID: 25651961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical results of proton beam therapy for hepatocellular carcinoma over 5 cm.
    Kimura K; Nakamura T; Ono T; Azami Y; Suzuki M; Wada H; Takayama K; Endo H; Takeyama T; Hirose K; Takai Y; Kikuchi Y
    Hepatol Res; 2017 Dec; 47(13):1368-1374. PubMed ID: 28198132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.
    Hata M; Tokuuye K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Ohara K; Matsuzaki Y; Tanaka N; Akine Y
    Cancer; 2005 Aug; 104(4):794-801. PubMed ID: 15981284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
    Cheng JC; Chuang VP; Cheng SH; Huang AT; Lin YM; Cheng TI; Yang PS; You DL; Jian JJ; Tsai SY; Sung JL; Horng CF
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):435-42. PubMed ID: 10802371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
    Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle Beam Therapy for Intrahepatic and Extrahepatic Biliary Duct Carcinoma: A Multi-Institutional Retrospective Data Analysis.
    Yamazaki H; Kimoto T; Suzuki M; Murakami M; Suzuki O; Takagi M; Katoh N; Arimura T; Ogino T; Ogino H
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma.
    Foo ML; Gunderson LL; Bender CE; Buskirk SJ
    Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):929-35. PubMed ID: 9369143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion.
    An J; Lee KS; Kim KM; Park DH; Lee SS; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
    Clin Mol Hepatol; 2017 Jun; 23(2):160-169. PubMed ID: 28506055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoembolisation for hepatocellular carcinoma with bile duct invasion: is preprocedural biliary drainage mandatory?
    Park J; Kim HC; Lee JH; Cho E; Kim M; Hur S; Jae HJ; Lee M; Chung JW
    Eur Radiol; 2018 Apr; 28(4):1540-1550. PubMed ID: 29124380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical results for hepatocellular carcinoma with bile duct invasion: a clinicopathologic comparison between macroscopic and microscopic tumor thrombus.
    Esaki M; Shimada K; Sano T; Sakamoto Y; Kosuge T; Ojima H
    J Surg Oncol; 2005 Jun; 90(4):226-32. PubMed ID: 15906365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Body Radiotherapy for Large Unresectable Hepatocellular Carcinomas - A Single Institution Phase II Study.
    Beaton L; Dunne EM; Yeung R; Rackley T; Weber B; Mar C; Yong-Hing CJ; Yoshida EM; DeVries K; Lee R; Duzenli C; Loewen SK; Liu M; Schellenberg D; Ma R
    Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):423-432. PubMed ID: 32093876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
    Sekino Y; Okumura T; Fukumitsu N; Iizumi T; Numajiri H; Mizumoto M; Nakai K; Nonaka T; Ishikawa H; Sakurai H
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):711-720. PubMed ID: 31776663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined modality treatment in unresectable extrahepatic biliary carcinoma.
    Morganti AG; Trodella L; Valentini V; Montemaggi P; Costamagna G; Smaniotto D; Luzi S; Ziccarelli P; Macchia G; Perri V; Mutignani M; Cellini N
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):913-9. PubMed ID: 10705013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.